Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2020 / Cilt: 25 - Sayı: 2

The Role and Importance of Chronic Diseases in COVID-19 and Related Recommendations

COVID-19’da Kronik Hastalıkların Rolü, Önemi ve Öneriler

Pages
132–138
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the literature information on the most common chronic diseases, with important role in COVID-19 course and mortality, is given.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In December 2019, a new coronavirus identified, named SARS-CoV-2, as a factor in the investigations conducted on the reporting of viral pneumonia cases in the Wuhan city of China, and the disease called “Coronavirus Disease 2019 (COVID-19)”.
📊
Key Findings & Data:Chronic diseases take the first line among the risk factors that increase the case fatality rates in COVID-19 outbreak worldwide.
💡
Conclusion & Impact:In this article, the literature information on the most common chronic diseases, with important role in COVID-19 course and mortality, is given.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

In December 2019, a new coronavirus identified, named SARS-CoV-2, as a factor in the investigations conducted on the reporting of viral pneumonia cases in the Wuhan city of China, and the disease called “Coronavirus Disease 2019 (COVID-19)”. Chronic diseases take the first line among the risk factors that increase the case fatality rates in COVID-19 outbreak worldwide. Chronic diseases that progress slowly, last for three months or more, caused by over one risk factor, usually show a complicated course and affect the quality of life of the person. In fact, chronic diseases caused a silent global epidemic, and together with the COVID-19 pandemic, they prepared a ground that increased the effects of the pandemic. The first data of COVID-19 increased our knowledge about the clinical characteristics of the disease and pointed out that the disease is more frequent and more severe in individuals with chronic disease. In this article, the literature information on the most common chronic diseases, with important role in COVID-19 course and mortality, is given.

Özet

Aralık 2019’da Çin’in Wuhan şehrinde nedeni bilinmeyen viral pnömoni olgularının bildirilmesi üzerine yapılan araştırmalarda etken olarak yeni bir koronavirüs saptanmış olup, SARS-CoV-2 adı verilen virüsün yaptığı hastalığa “Koronavirüs Hastalığı 2019 (COVID- 19)” adı verilmiştir. Kronik hastalıklar tüm dünyada, COVID-19 salgınında olgu fatalite oranlarını arttıran risk faktörleri arasında birinci sırada yer almaktadır. Kronik hastalıklar, yavaş ilerleyen, üç ay ve daha uzun süreli, birden fazla risk faktörünün neden olduğu, genellikle komplike bir seyir gösteren ve kişinin yaşam kalitesini etkileyen hastalıklardır. Esasında, kronik hastalıklar sessiz bir küresel salgın oluşturmuş, COVID-19 salgını ile beraber salgının etkilerini arttıran bir zemin hazırlamıştır. COVID-19’a ait ilk veriler hastalığın klinik karakteristiği hakkında bilgilerimizi arttırmış olup kronik hastalığı olan bireylerde hastalığın daha sık görüldüğü ve daha ağır seyrettiğine dikkat çekmiştir. Bu yazıda COVID-19 seyrinde ve mortalitesinde önemli bir yer tutan ve en sık görülen kronik hastalıklar ile ilgili literatür bilgisine yer verilmiştir.

🔖

Cite This Article

SANDALCI, B., UYAROĞLU, O. A., GÜVEN, G. S. (2020). The Role and Importance of Chronic Diseases in COVID-19 and Related Recommendations. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 25 - Sayı: 2, 132–138. https://ajindex.com/articles/157046

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Available from:
  2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382(18):1708-20
  3. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-81
  4. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis. J Med Virol 2020
  5. Organization WH. Noncommunicable diseases [Available from: https://www.who.int/news-room/fact-sheets/detail/ noncommunicable-diseases
  6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507-13
  7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID- 19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62. 8. de Abajo FJ, Rodriguez-Martin S, Lerma V, Mejia-Abril G, Aguilar M, Garcia-Luque A, et al. Use of renin-angiotensin- aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet 2020;395(10238):1705-14
  8. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020;14(4):303-10
  9. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574-81
  10. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med 2020
  11. Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metabolism 2020
  12. Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID- 19 patients: a systemic review and meta-anal